Agaricus blazei Murrill, commonly called Himematsutake or the Royal Sun mushroom, is a basidiomycete fungus of Brazilian origin that has attracted considerable scientific attention since the 1980s. It is cultivated widely in Japan and Brazil and is among the more studied functional mushrooms in relation to immune function. This overview summarizes what the research currently indicates about its bioactive constituents, immunological effects, and clinical evidence.
Species Background and Traditional Use
Agaricus blazei Murrill (AbM) was first identified in the Piedade region of Brazil, where it was consumed by local populations with reportedly low rates of certain chronic diseases. This observation prompted interest from Japanese researchers in the 1960s, leading to commercial cultivation beginning in Japan. The species is sometimes referred to as Agaricus subrufescens in updated taxonomic classifications, though A. blazei Murrill remains the name most commonly used in the scientific literature.
Traditional use spans applications including immune support, liver health, and general tonic effects. Its widespread adoption as a health food supplement in Japan and Brazil positioned it as a candidate for systematic investigation, and over the subsequent decades a substantial body of preclinical and some clinical research has accumulated.
Bioactive Constituents
The immunological activity of A. blazei is attributed primarily to its beta-glucan polysaccharides, though the full picture of its bioactive profile includes additional constituents:
- Beta-glucans: High-molecular-weight polysaccharides including beta-1,3 and beta-1,6-glucan fractions that interact with pattern recognition receptors on innate immune cells, particularly Dectin-1 on macrophages and dendritic cells.
- Proteoglycans: Protein-polysaccharide complexes that may contribute to immune cell activation through distinct receptor pathways.
- Agaritine: An aromatic amine unique to Agaricus species; its bioavailability and significance at typical supplemental intakes remains a subject of ongoing study.
- Ergosterol and sterols: Precursors to vitamin D2 and potential contributors to anti-inflammatory activity.
The composition of AbM preparations varies considerably depending on extraction method, growing substrate, and whether the preparation derives from the fruiting body, mycelium, or dried whole mushroom. Water extracts and ethanol extracts produce different compound profiles, and research indicates this distinction has meaningful implications for immunological effects.[1]
Immunomodulatory Mechanisms: Laboratory Evidence
A substantial body of in vitro and preclinical research has investigated how AbM extracts interact with immune cells. Studies consistently indicate that water-based extracts of AbM may stimulate the activity of natural killer (NK) cells, macrophages, and other innate immune cell populations. Research examining water versus ethanol extracts of several medicinal mushrooms including AbM found that water extracts enhanced NK cell cytotoxic activity against cancer cells and stimulated expression of cytolytic proteins including perforin and granulysin, as well as upregulation of NKG2D and NCR surface receptors. Ethanol extracts, by contrast, inhibited NK cell cytotoxicity, suggesting that extraction method fundamentally determines the nature of the immunological effect produced.[1]
Additional mechanistic research published in PLoS One examined the effect of AbM water extracts on human macrophages and found that AbM enhanced transcription of interleukin-1 beta (IL-1 beta) and triggered activation of the NLRP3 inflammasome, a multiprotein complex involved in innate immune signaling. AbM-mediated IL-1 beta secretion was markedly reduced in macrophages deficient in NLRP3 and ASC, establishing that inflammasome activation is a core pathway through which AbM exerts its immunostimulatory effects on human macrophage cells. The study further identified caspase-1 activation and reactive oxygen species generation as contributing mechanisms.[2]
These mechanistic studies provide a plausible cellular basis for the immunological activity observed in human studies, though the relevance of in vitro findings to whole-organism supplementation at commercially available concentrations requires continued investigation.
Clinical Evidence: Human Studies
NK Cell Activity in Cancer Patients
One of the more methodologically structured human studies of AbM was conducted with gynecological cancer patients undergoing chemotherapy. In this study, 100 patients with cervical, ovarian, or endometrial cancer receiving carboplatin-based chemotherapy were assigned to either consume an AbM extract (Agaricus blazei Murill Kyowa, ABMK) or placebo alongside their treatment. NK cell activity was found to be significantly higher in the ABMK-treated group compared to the non-treated group (ANOVA, p less than 0.002). Chemotherapy-associated side effects including reduced appetite, alopecia severity, emotional instability, and general weakness were also reported as improved in the ABMK-treated group. The authors concluded that ABMK consumption may be beneficial for gynecological cancer patients undergoing chemotherapy, while noting that lymphokine-activated killer and monocyte activities did not differ significantly between groups.[3]
This finding is consistent with the in vitro literature on NK cell activation and represents one of the more frequently cited human data points for AbM. The study population, however, was specific to cancer patients on active chemotherapy, and findings should not be extrapolated directly to healthy individuals.
Broader Clinical Review Findings
A comprehensive review article covering preclinical and clinical research on AbM alongside the related species Hericium erinaceus (Lion’s Mane) and Grifola frondosa (Maitake) identified several recurring findings across the human and animal literature. Antitumor mechanisms identified included both direct tumor cell attack (apoptosis induction and metastatic suppression) and indirect immune defense (T helper cell 1 immune response enhancement and inhibited tumor neovascularization). Anti-inflammatory effects were observed as reductions in pro-inflammatory cytokines and oxidative stress markers. The mushrooms were described as appearing safe in the reviewed studies and were noted to increase longevity in animal models, possibly due to reduced tumorigenesis and oxidative burden. The review authors noted that a predominant Th2 immune environment is associated with both allergy and cancer contexts, and that AbM’s potential to modulate the Th1/Th2 balance may be relevant across these conditions.[4]
Antitumor Research: Context and Limitations
Much of the AbM research literature, particularly the earlier work from Japan and Brazil, focused on antitumor properties. Preclinical models demonstrated that AbM polysaccharide fractions could inhibit tumor growth in animal models, and some clinical studies explored its use as an adjunct to conventional cancer treatment. The human evidence in this area is promising but limited in scale. Most human trials are small, lack rigorous blinding, and focus on surrogate immune endpoints such as NK cell activity rather than primary clinical outcomes.
It is important to be clear that AbM is not a cancer treatment. The research examines potential immunological support effects in adjunct contexts, and no regulatory body has approved AbM preparations for the treatment of any cancer or disease. The available evidence suggests a plausible role in supporting immune cell activity, but this is distinct from a direct anti-cancer application.
Comparison With Other Functional Mushrooms
Within the broader functional mushroom landscape, AbM occupies a position similar to Turkey Tail (Trametes versicolor) and Reishi (Ganoderma lucidum) in that its primary research interest is immunological. Its beta-glucan content and NK cell stimulating properties align it with the immune-focused category of functional mushrooms, rather than the neurotrophic category occupied by Lion’s Mane or the skin and gut-focused applications of Tremella.
For those evaluating AbM within a broader functional mushroom supplement strategy, understanding how different species may complement each other provides useful context. Our overview of mushrooms and gut immune effects covers the prebiotic and mucosal immune dimensions that may operate in parallel with AbM’s more systemic NK cell activity.
Safety Considerations
AbM has a long history of consumption as a food and supplement with a generally favorable safety record. Human studies have not identified significant adverse effects at typical supplemental intakes. However, a few safety considerations are relevant:
- Agaritine content: AbM contains agaritine, a compound with genotoxic potential in high-dose animal studies. Available evidence suggests that agaritine is largely destroyed during cooking and that typical supplemental intakes are well below levels of concern, but individuals consuming raw or unprocessed preparations in high quantities should be aware of this compound.
- Hepatic effects: Case reports of hepatotoxicity have been associated with Agaricus preparations in some literature, though the evidence is limited and product quality variability complicates causal attribution.
- Drug interactions: Given AbM’s immunomodulatory activity, individuals taking immunosuppressant medications, undergoing chemotherapy, or managing autoimmune conditions should consult a healthcare provider before use. Interactions with blood glucose-lowering medications have also been noted as a theoretical concern based on preclinical hypoglycemic data.
Summary
Research suggests that Agaricus blazei Murrill may support NK cell activity and innate immune function through beta-glucan polysaccharide fractions that activate macrophage and natural killer cell pathways. The most clinically relevant human evidence involves its potential to support immune parameters in cancer patients receiving chemotherapy, where one human trial found significantly higher NK cell activity in AbM-treated patients. Preclinical mechanistic studies provide a credible cellular basis for these effects. As with all functional mushrooms, AbM should not be regarded as a substitute for evidence-based medical treatment, and individuals with existing health conditions or taking medications should seek guidance from a qualified healthcare provider before beginning supplementation.
References
- [1] Lu CC, et al. Immunomodulatory properties of medicinal mushrooms: differential effects of water and ethanol extracts on NK cell-mediated cytotoxicity. Innate Immun. 2016;22(7):522-33. PMID: 27469258
- [2] Huang TT, et al. The anti-tumorigenic mushroom Agaricus blazei Murill enhances IL-1beta production and activates the NLRP3 inflammasome in human macrophages. PLoS One. 2012;7(7):e41383. PMID: 22844468
- [3] Ahn WS, et al. Natural killer cell activity and quality of life were improved by consumption of a mushroom extract, Agaricus blazei Murill Kyowa, in gynecological cancer patients undergoing chemotherapy. Int J Gynecol Cancer. 2004;14(4):589-94. PMID: 15304151
- [4] Hetland G, et al. Antitumor, Anti-Inflammatory and Antiallergic Effects of Agaricus blazei Mushroom Extract and the Related Medicinal Basidiomycetes Mushrooms, Hericium erinaceus and Grifola frondosa. Nutrients. 2020;12(5):1339. PMID: 32397163
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Mushroom supplements are not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before starting any new supplement, especially if you have an existing medical condition or take medications.
